Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

DeepLPI: a novel deep learning-based model for protein-ligand interaction prediction for drug repurposing

Open access
Wei, Bomin, Zhang, Yue, Gong, Xiang · 2021 · Scientific Reports

Preprint — published as 10.1038/s41598-022-23014-1 · Paper page

Abstract

The substantial cost of new drug research and development has consistently posed a huge burden for both pharmaceutical companies and patients. In order to lower the expenditure and development failure rate, repurposing existing and approved drugs by identifying interactions between drug molecules and target proteins based on computational methods have gained growing attention. Here, we propose the DeepLPI, a novel deep learning-based model that mainly consists of ResNet-based 1-dimensional convolutional neural network (1D CNN) and bi-directional long short term memory network (biLSTM), to establish an end-to-end framework for protein-ligand interaction prediction. We first encode the raw drug molecular sequences and target protein sequences into dense vector representations, which go through two ResNet-based 1D CNN modules to derive features, respectively. The extracted feature vectors are concatenated and further fed into the biLSTM network, followed by the MLP module to finally predict protein-ligand interaction. We downloaded the well-known BindingDB and Davis dataset for training and testing our DeepLPI model. We also applied DeepLPI on a COVID-19 dataset for externally evaluating the prediction ability of DeepLPI. To benchmark our model, we compared our DeepLPI with the state-of-the-art methods of DeepCDA and DeepDTA, and observed that our DeepLPI outperformed these methods, suggesting the high accuracy of the DeepLPI towards protein-ligand interaction prediction. The high prediction performance of DeepLPI on the different datasets displayed its high capability of protein-ligand interaction in generalization, demonstrating that the DeepLPI has the potential to pinpoint new drug-target interactions and to find better destinations for proven drugs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2021.12.01.470868

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Distribution of BindingDB data used to develop the DeepLPI model. (a) Distribution of the pKd values and the threshold for determining active/inactive. (b) Distribution of interaction in binary classes. (c) Distribution of lengths of protein sequences. (d) Distribution of lengths of drug molecular SMILES strings.
Figure 1 Distribution of BindingDB data used to develop the DeepLPI model. (a) Distribution of the pKd values and the threshold for determining active/inactive. (b) Distribution of interaction in binary classes. (c) Distribution of lengths of protein sequences. (d) Distribution of lengths of drug molecular SMILES strings.CC BY · PubMed Central
Figure 2 The overview of the DeepLPI model.
Figure 2 The overview of the DeepLPI model.CC BY · PubMed Central
Figure 3 The loss and AUROC score during the DeepLPI training on the BindingDB Kd dataset. (a) Loss scores for training and validation. (b) AUROC scores for training and validation.
Figure 3 The loss and AUROC score during the DeepLPI training on the BindingDB Kd dataset. (a) Loss scores for training and validation. (b) AUROC scores for training and validation.CC BY · PubMed Central
Figure 4 The prediction performance of the final DeepLPI model on BindingDB dataset. (a) The ROC curve and the determined optimal threshold. (b) Confusion matrix based on the optimal threshold. (c–e) Confusion matrix and performance metrics on the three “unseen” drug/protein testsets: (c) Molecule unseen, (d) Protein unseen and (e) None seen.
Figure 4 The prediction performance of the final DeepLPI model on BindingDB dataset. (a) The ROC curve and the determined optimal threshold. (b) Confusion matrix based on the optimal threshold. (c–e) Confusion matrix and performance metrics on the three “unseen” drug/protein testsets: (c) Molecule unseen, (d) Protein unseen and (e) None seen.CC BY · PubMed Central
Figure 5 The loss and AUROC score during the DeepLPI training on Davis dataset (a) loss scores for training and validation. (b) AUROC scores for training and validation.
Figure 5 The loss and AUROC score during the DeepLPI training on Davis dataset (a) loss scores for training and validation. (b) AUROC scores for training and validation.CC BY · PubMed Central
Figure 6 The prediction performance of the final DeepLPI model Davis dataset. (a) The ROC curve and the determined optimal threshold. (b) Confusion matrix based on the optimal threshold on the combined "unseen" testing sets. (c–e) Confusion matrix and performance metrics on the three unseen drug/protein testsets: (c) Molecule unseen, (d) Protein unseen and (e) None seen.
Figure 6 The prediction performance of the final DeepLPI model Davis dataset. (a) The ROC curve and the determined optimal threshold. (b) Confusion matrix based on the optimal threshold on the combined "unseen" testing sets. (c–e) Confusion matrix and performance metrics on the three unseen drug/protein testsets: (c) Molecule unseen, (d) Protein unseen and (e) None seen.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 24

  1. 10.1038/nrd.2018.168 · DOI · Paper page
  2. 10.1001/jama.2020.1166 · DOI · Paper page
  3. 10.4103/0975-7406.72130 · DOI
  4. 10.1371/journal.ppat.1008341 · DOI
  5. 10.1016/j.drudis.2016.10.008 · DOI
  6. 10.3390/ijms22094435 · DOI · Paper page
  7. I. Wallach , M. Dzamba , and A. Heifets , “AtomNet: a deep convolutional neural network for bioactivity prediction in structure-based drug discovery.” arXiv preprint arXiv:1510.02855 (2015). · arXiv
  8. 10.3389/fgene.2020.607824 · DOI
  9. 10.1093/bioinformatics/btu626 · DOI · Paper page
  10. 10.1136/bmj.324.7344.1018 · DOI · Paper page
  11. 10.1093/bioinformatics/btq112 · DOI · Paper page
  12. 10.3390/molecules200610947 · DOI
  13. 10.1109/IJCNN.2016.7727339 · DOI
  14. 10.1093/bioinformatics/bty593 · DOI · Paper page
  15. 10.1093/bioinformatics/btaa544 · DOI · Paper page
  16. 10.1021/acs.jcim.7b00616 · DOI · Paper page
  17. 10.1016/j.cels.2021.05.017 · DOI · Paper page
  18. 10.1093/nar/gkl999 · DOI · Paper page
  19. 10.1038/nbt.1990 · DOI · Paper page
  20. Huang, K. et al, “Therapeutics Data Commons: Machine Learning Datasets and Tasks for Drug Discovery and Development”, arXiv preprints, 2021. arXiv:2102.09548 · arXiv
  21. 10.1021/ci100050t · DOI · Paper page
  22. 10.1109/CVPR.2016.90 · DOI · Paper page
  23. 10.1109/ICCV.2015.123 · DOI · Paper page
  24. D. P. Kingma and J. Ba , “Adam: A Method for Stochastic Optimization,” arXiv preprint arXiv: 1412.6980 (2014). · arXiv

Metadata

Authors
Wei, B., Zhang, Y., & Gong, X.
Affiliations
  • Princeton University (US)
  • University of Utah (US)
Corresponding author
Wei, Bomin
Venue
Scientific Reports
Publisher
openRxiv
Published
2021-12-03
Volume
12
Issue
1
Pages
18200-18200
ISSN
2045-2322 (ISSN-L)
OpenAlex
W4307479771
Cited by
53
References
1
Citations by year
2026: 8 · 2025: 18 · 2024: 18 · 2023: 8 · 2022: 1
FWCI
6.09
Type
journal article
Language
en
Open access
Licence
cc-by
Locations
  • Scientific Reports (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Machine Learning in Bioinformatics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Interaction Studies and Fluorescence Analysis
Keywords
protein-ligand interaction prediction, drug repurposing, 1D convolutional neural network, bidirectional LSTM, ResNet, drug-target interactions, COVID-19 drug targets, BindingDB
MeSH terms
Deep Learning, COVID-19 Drug Treatment, Humans, Ligands, Neural Networks, Computer, Drug Repositioning

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.